84509-102-01 : NDC 2026 Code

84509-102-01 : Zinc Oxide,niacinamide,colloidal Sulfur,azelaic Acid,salicylic Acid. ( Acne Buster Salicylic Acid Drying Serum )

Additionally :

You can get information about “84509-102-01” NDC code in 84509-102-01 in HTML format

HTML | 84509-102-01 in TXT (Plain Text) format

TXT | 84509-102-01 in PDF (Portable Document Format)

PDF | 84509-102-01 in XML format

XML formats.

NDC Code : 84509-102-01 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "84509-102-01",
    "PackageDescription": "10 mL in 1 BOTTLE (84509-102-01) ",
    "NDC11Code": "84509-0102-01",
    "ProductNDC": "84509-102",
    "ProductTypeName": "HUMAN OTC DRUG",
    "ProprietaryName": "Acne Buster Salicylic Acid Drying Serum",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Zinc Oxide,niacinamide,colloidal Sulfur,azelaic Acid,salicylic Acid.",
    "DosageFormName": "LIQUID",
    "RouteName": "TOPICAL",
    "StartMarketingDate": "20260306",
    "EndMarketingDate": null,
    "MarketingCategoryName": "OTC MONOGRAPH DRUG",
    "ApplicationNumber": "M016",
    "LabelerName": "Guangzhou Senmai Biotechnology Co.,Ltd.",
    "SubstanceName": "AZELAIC ACID; NIACINAMIDE; SALICYLIC ACID; SULFUR; ZINC OXIDE",
    "StrengthNumber": ".024; .05; .018; .03; .2",
    "StrengthUnit": "mg/10mL; mg/10mL; mg/10mL; mg/10mL; mg/10mL",
    "Pharm_Classes": "Decreased Protein Synthesis [PE], Decreased Sebaceous Gland Activity [PE]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2026-03-10",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20271231",
    "StartMarketingDatePackage": "20260306",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}